Search

Your search keyword '"Skardal, R."' showing total 123 results

Search Constraints

Start Over You searched for: "Skardal, R." Remove constraint "Skardal, R."
123 results on '"Skardal, R."'

Search Results

1. Infective endocarditis in adult patients with congenital heart disease

2. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

3. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure:a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

4. Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (Infection, (2022), 50, 5, (1191-1202), 10.1007/s15010-022-01792-0)

5. Socio-Economic Variations Determine the Clinical Presentation, Aetiology and Outcome of Infective Endocarditis: a Prospective Cohort Study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) Registry

6. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

7. EURObservational Research Programme:regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

8. EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

9. Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

10. Beyond the Obstructive Paradigm: Unveiling the Complex Landscape of Nonobstructive Coronary Artery Disease.

11. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

13. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

15. Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers.

16. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study

17. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

18. Multicellular bioprinted skin facilitates human-like skin architecture in vivo.

19. Electrographic flow mapping guided catheter ablation offers advantages for patients with persistent atrial fibrillation.

20. Novel Functional Dressing Materials for Intraoral Wound Care.

21. Myocardial Recovery.

22. Rotor mechanism and its mapping in atrial fibrillation.

23. Harnessing Human Placental Membrane-Derived Bioinks: Characterization and Applications in Bioprinting and Vasculogenesis.

24. High-impact opportunities to address ischemia: a focus on heart and circulatory research.

25. INSIGHTS INTO THE METABOLISM AND CLINICAL SIGNIFICANCE OF VITAMIN K IN UREMIA: MORE THAN A SUPPLEMENT?

26. COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy.

27. Intervention and in-hospital pharmacoterapies in octogenarian with acute coronary syndrome: a 10-year retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry.

28. High vitamin K status is prospectively associated with decreased left ventricular mass in women: the Hoorn Study.

29. Proposal for the use of echocardiography in bloodstream infections due to different streptococcal species.

30. Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance.

31. Sequential ultrahigh‐density contact mapping of persistent atrial fibrillation: An efficient technique for driver identification.

32. Generalized synchronization on the onset of auxiliary system approach.

33. Complex networks exhibit intermittent synchronization.

34. Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature.

35. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.

36. SYNCHRONIZATION OF NETWORK-COUPLED OSCILLATORS WITH UNCERTAIN DYNAMICS.

37. Galectin‐3 as a candidate upstream biomarker for quantifying risks of myocardial ageing.

38. An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure.

39. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.

40. Clinical and regulatory considerations for novel electrophysiology mapping systems: Lessons from FIRM.

41. Matters of Life and Death: Racism, Patriotism, and Policing in All American Boys.

42. Pro‐gastrin‐releasing peptide and outcome in patients with heart failure and anaemia: results from the RED‐HF study.

43. Catheter ablation of atrial fibrillation in heart failure with reduced ejection fraction.

44. Clinical impact of rotor ablation in atrial fibrillation: a systematic review.

45. Stability Diagram, Hysteresis, and Critical Time Delay and Frequency for the Kuramoto Model with Heterogeneous Interaction Delays.

46. Efficacy and safety of driver-guided catheter ablation for atrial fibrillation: A systematic review and meta-analysis.

47. Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.

50. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Catalog

Books, media, physical & digital resources